Proteomic analysis identifies HMGA2 as a novel biomarker of overall survival in papillary renal cell carcinoma

Proteomic analysis identifies HMGA2 as a novel biomarker of overall survival in papillary renal cell carcinoma

Abstract Purpose Although papillary renal cell carcinoma (PRCC) has a relatively favorable prognosis, a small number of patients with lymph node or distant metastasis have a poor prognosis. Owing to the complex typing and heterogeneity of PRCC, it remains difficult to provide risk stratification. Th...

Full description

Bibliographic Details
Main Authors: Tian Wei, Huiya Xu, Huishan Liang, Yating Lian, Huiyu Chen, Zhangyi Zheng, Minghui Zhong, Junfeng Liu, Ran Wang, Fen Wang
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Cancer Medicine
Subjects:
HMGA2
papillary renal cell carcinoma
prognosis
proteomics
TCGA
Online Access:https://doi.org/10.1002/cam4.6077

Internet

https://doi.org/10.1002/cam4.6077

Similar Items